KPIs & Operating Metrics(New)
Balance Sheet
AssetsCash & Current InvestmentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPensionPreferred SharesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsSecurities - TradableShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allstate (ALL) Cash & Equivalents (2019)

Allstate (ALL) has disclosed Cash & Equivalents for 10 consecutive years, with $64.7 billion as the latest value for Q3 2024.

  • On a quarterly basis, Cash & Equivalents changed N/A to $64.7 billion in Q3 2024 year-over-year; TTM through Sep 2024 was $64.7 billion, a N/A change, with the full-year FY2021 number at $53.3 billion, changed N/A from a year prior.
  • Cash & Equivalents was $64.7 billion for Q3 2024 at Allstate, up from $50.7 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $64.7 billion in Q3 2024 to a low of $50.5 billion in Q1 2022.
  • A 3-year average of $54.8 billion and a median of $52.0 billion in 2021 define the central range for Cash & Equivalents.